Wells Fargo’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$580 Hold
200
﹤0.01% 5899
2025
Q1
$144 Hold
200
﹤0.01% 5880
2024
Q4
$206 Hold
200
﹤0.01% 5855
2024
Q3
$268 Sell
200
-800
-80% -$1.07K ﹤0.01% 5802
2024
Q2
$1.3K Buy
1,000
+460
+85% +$598 ﹤0.01% 5687
2024
Q1
$929 Buy
540
+7
+1% +$12 ﹤0.01% 5775
2023
Q4
$784 Buy
533
+18
+3% +$26 ﹤0.01% 5843
2023
Q3
$623 Sell
515
-14
-3% -$17 ﹤0.01% 5944
2023
Q2
$767 Buy
529
+18
+4% +$26 ﹤0.01% 6079
2023
Q1
$741 Buy
511
+103
+25% +$149 ﹤0.01% 6137
2022
Q4
$706 Buy
408
+5
+1% +$9 ﹤0.01% 5960
2022
Q3
$0 Sell
403
-488
-55% ﹤0.01% 6971
2022
Q2
$1K Sell
891
-13,392
-94% -$15K ﹤0.01% 6295
2022
Q1
$124K Sell
14,283
-8,411
-37% -$73K ﹤0.01% 4897
2021
Q4
$363K Buy
22,694
+14,928
+192% +$239K ﹤0.01% 4585
2021
Q3
$144K Sell
7,766
-32,081
-81% -$595K ﹤0.01% 4950
2021
Q2
$556K Buy
39,847
+21,927
+122% +$306K ﹤0.01% 4298
2021
Q1
$265K Sell
17,920
-23,879
-57% -$353K ﹤0.01% 4715
2020
Q4
$811K Buy
41,799
+8,424
+25% +$163K ﹤0.01% 4115
2020
Q3
$373K Sell
33,375
-3,811
-10% -$42.6K ﹤0.01% 4436
2020
Q2
$503K Buy
37,186
+10,390
+39% +$141K ﹤0.01% 4203
2020
Q1
$217K Buy
26,796
+7,171
+37% +$58.1K ﹤0.01% 4468
2019
Q4
$189K Buy
19,625
+2,351
+14% +$22.6K ﹤0.01% 4827
2019
Q3
$183K Buy
17,274
+3,614
+26% +$38.3K ﹤0.01% 4817
2019
Q2
$157K Buy
13,660
+8,915
+188% +$102K ﹤0.01% 4906
2019
Q1
$61K Sell
4,745
-9,495
-67% -$122K ﹤0.01% 5179
2018
Q4
$88K Buy
14,240
+11,906
+510% +$73.6K ﹤0.01% 5098
2018
Q3
$25K Buy
2,334
+1,517
+186% +$16.2K ﹤0.01% 5445
2018
Q2
$12K Sell
817
-236
-22% -$3.47K ﹤0.01% 5571
2018
Q1
$15K Buy
1,053
+63
+6% +$897 ﹤0.01% 5505
2017
Q4
$11K Buy
+990
New +$11K ﹤0.01% 5533